Evidence map›Paper›PMID 38713621›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

A TME-enlightened protein-binding photodynamic nanoinhibitor for highly effective oncology treatment.

Zepeng Cui, Baoxuan Huang, Jiahao Zheng, Jia Tian, Weian Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Shedding light on the cancer cell death mechanism in photodynamic therapy.Apoptosis : an international journal on programmed cell death · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zepeng CuiShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, People's Republic of China.ORCID 0000-0002-1717-597X
Baoxuan HuangShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, People's Republic of China.
Jiahao ZhengShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, People's Republic of China.ORCID 0009-0002-1437-5420
Jia TianShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, People's Republic of China.ORCID 0000-0001-7391-4522
Weian ZhangShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, People's Republic of China.

Funding

MOST | National Natural Science Foundation of China (NSFC) 22075079MOST | National Natural Science Foundation of China (NSFC) 52333014Science and Technology Commission of Shanghai Municipality (STCSM) 21520713400Science and Technology Commission of Shanghai Municipality (STCSM) 21ZR1417800Science and Technology Commission of Shanghai Municipality (STCSM) 22142201100Science and Technology Commission of Shanghai Municipality (STCSM) 23J21901600
6 · The paper itself

Abstract

The efficiency of photodynamic therapy (PDT) is greatly dependent on intrinsic features of photosensitizers (PSs), but most PSs suffer from narrow diffusion distances and short life span of singlet oxygen (

Indexed as

PhotochemotherapyPhotosensitizing AgentsTumor MicroenvironmentAnimalsCell Line, TumorHumansMiceNanoparticlesNeoplasmsPorphyrinsProtein BindingSinglet OxygenbacteriochlorinPhotosensitizing AgentsPorphyrinsSinglet Oxygenphotodynamic immunotherapyprotein-bindingtetrafluorophenyl bacteriochlorin

Identifiers

PMID38713621
PMCPMC11098098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.